High-fat diet prevents the development of autoimmune diabetes in NOD mice. 2021

Amy L Clark, and Zihan Yan, and Sophia X Chen, and Victoria Shi, and Devesha H Kulkarni, and Abhinav Diwan, and Maria S Remedi
Department of Pediatrics, Washington University in St Louis, St Louis, Missouri, USA.

Type 1 diabetes (T1D) has a strong genetic predisposition and requires an environmental trigger to initiate the beta-cell autoimmune destruction. The rate of childhood obesity has risen in parallel to the proportion of T1D, suggesting high-fat diet (HFD)/obesity as potential environmental triggers for autoimmune diabetes. To explore this, non-obese diabetic (NOD) mice were subjected to HFD and monitored for the development of diabetes, insulitis and beta-cell stress. Four-week-old female NOD mice were placed on HFD (HFD-NOD) or standard chow-diet. Blood glucose was monitored weekly up to 40 weeks of age, and glucose- and insulin-tolerance tests performed at 4, 10 and 15 weeks. Pancreata and islets were analysed for insulin secretion, beta-cell mass, inflammation, insulitis and endoplasmic reticulum stress markers. Immune cell levels were measured in islets and spleens. Stool microbiome was analysed at age 4, 8 and 25 weeks. At early ages, HFD-NOD mice showed a significant increase in body weight, glucose intolerance and insulin resistance; but paradoxically, they were protected from developing diabetes. This was accompanied by increased insulin secretion and beta-cell mass, decreased insulitis, increased splenic T-regulatory cells and altered stool microbiome. This study shows that HFD protects NOD mice from autoimmune diabetes and preserves beta-cell mass and function through alterations in gut microbiome, increased T-regulatory cells and decreased insulitis. Further studies into the exact mechanism of HFD-mediated prevention of diabetes in NOD mice could potentially lead to interventions to prevent or delay T1D development in humans.

UI MeSH Term Description Entries
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016688 Mice, Inbred NOD A strain of non-obese diabetic mice developed in Japan that has been widely studied as a model for T-cell-dependent autoimmune insulin-dependent diabetes mellitus in which insulitis is a major histopathologic feature, and in which genetic susceptibility is strongly MHC-linked. Non-Obese Diabetic Mice,Mice, NOD,Mouse, Inbred NOD,Mouse, NOD,Non-Obese Diabetic Mouse,Nonobese Diabetic Mice,Nonobese Diabetic Mouse,Diabetic Mice, Non-Obese,Diabetic Mice, Nonobese,Diabetic Mouse, Non-Obese,Diabetic Mouse, Nonobese,Inbred NOD Mice,Inbred NOD Mouse,Mice, Non-Obese Diabetic,Mice, Nonobese Diabetic,Mouse, Non-Obese Diabetic,Mouse, Nonobese Diabetic,NOD Mice,NOD Mice, Inbred,NOD Mouse,NOD Mouse, Inbred,Non Obese Diabetic Mice,Non Obese Diabetic Mouse
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D059305 Diet, High-Fat Consumption of excessive DIETARY FATS. Diet, High Fat,Diets, High Fat,Diets, High-Fat,High Fat Diet,High Fat Diets,High-Fat Diet,High-Fat Diets
D063766 Pediatric Obesity BODY MASS INDEX in children (ages 2-12) and in adolescents (ages 13-18) that is grossly above the recommended cut-off for a specific age and sex. For infants less than 2 years of age, obesity is determined based on standard weight-for-length percentile measures. Childhood Obesity,Adolescent Obesity,Adolescent Overweight,Child Obesity,Childhood Onset Obesity,Childhood Overweight,Infant Obesity,Infant Overweight,Infantile Obesity,Obesity in Adolescence,Obesity in Childhood,Obesity, Adolescent,Obesity, Child,Obesity, Childhood,Obesity, Childhood Onset,Obesity, Infant,Obesity, Infantile,Obesity, Pediatric,Overweight, Adolescent,Overweight, Childhood,Overweight, Infant

Related Publications

Amy L Clark, and Zihan Yan, and Sophia X Chen, and Victoria Shi, and Devesha H Kulkarni, and Abhinav Diwan, and Maria S Remedi
May 2019, International immunopharmacology,
Amy L Clark, and Zihan Yan, and Sophia X Chen, and Victoria Shi, and Devesha H Kulkarni, and Abhinav Diwan, and Maria S Remedi
October 2015, Scientific reports,
Amy L Clark, and Zihan Yan, and Sophia X Chen, and Victoria Shi, and Devesha H Kulkarni, and Abhinav Diwan, and Maria S Remedi
April 2015, Toxicology and applied pharmacology,
Amy L Clark, and Zihan Yan, and Sophia X Chen, and Victoria Shi, and Devesha H Kulkarni, and Abhinav Diwan, and Maria S Remedi
August 1999, Diabetes,
Amy L Clark, and Zihan Yan, and Sophia X Chen, and Victoria Shi, and Devesha H Kulkarni, and Abhinav Diwan, and Maria S Remedi
June 2004, Immunity,
Amy L Clark, and Zihan Yan, and Sophia X Chen, and Victoria Shi, and Devesha H Kulkarni, and Abhinav Diwan, and Maria S Remedi
January 1999, Diabetes/metabolism research and reviews,
Amy L Clark, and Zihan Yan, and Sophia X Chen, and Victoria Shi, and Devesha H Kulkarni, and Abhinav Diwan, and Maria S Remedi
January 2015, Journal of diabetes research,
Amy L Clark, and Zihan Yan, and Sophia X Chen, and Victoria Shi, and Devesha H Kulkarni, and Abhinav Diwan, and Maria S Remedi
July 1991, Diabetes research (Edinburgh, Scotland),
Amy L Clark, and Zihan Yan, and Sophia X Chen, and Victoria Shi, and Devesha H Kulkarni, and Abhinav Diwan, and Maria S Remedi
January 2011, The American journal of Chinese medicine,
Amy L Clark, and Zihan Yan, and Sophia X Chen, and Victoria Shi, and Devesha H Kulkarni, and Abhinav Diwan, and Maria S Remedi
December 2019, Scientific reports,
Copied contents to your clipboard!